
Bacterial Postbiotics as Promising Tools to Mitigate Cardiometabolic Diseases
Author(s) -
Fernando F. Anhê,
Benjamin Anderschou Holbech Jensen,
Laís R Perazza,
André Tchernof,
Jonathan D. Schertzer,
André Marette
Publication year - 2021
Publication title -
journal of lipid and atherosclerosis
Language(s) - English
Resource type - Journals
eISSN - 2288-2561
pISSN - 2287-2892
DOI - 10.12997/jla.2021.10.2.123
Subject(s) - medicine
Gut microbes dictate critical features of host immunometabolism. Certain bacterial components and metabolites (termed postbiotics) mitigate cardiometabolic diseases whereas others potentiate pathological processes. In this review, we discuss key aspects related to the usefulness of bacterial-related molecules strategically positioned as promising treatment strategies for cardiometabolic diseases.